1.02
전일 마감가:
$0.9705
열려 있는:
$0.9772
하루 거래량:
20,040
Relative Volume:
0.15
시가총액:
$45.50M
수익:
-
순이익/손실:
$-21.38M
주가수익비율:
-2.6154
EPS:
-0.39
순현금흐름:
$-25.19M
1주 성능:
+0.96%
1개월 성능:
+38.43%
6개월 성능:
-8.78%
1년 성능:
-18.76%
코넥트 바이오파마 Stock (CNTB) Company Profile
명칭
Connect Biopharma Holdings Ltd Adr
전화
858-727-1040
주소
3580 CARMEL MOUNTAIN ROAD, SUITE 200, SAN DIEGO
CNTB을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
CNTB
Connect Biopharma Holdings Ltd Adr
|
1.04 | 45.50M | 0 | -21.38M | -25.19M | -0.39 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
443.30 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
528.60 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
317.35 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
562.31 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
241.88 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
코넥트 바이오파마 Stock (CNTB) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-06-12 | 개시 | H.C. Wainwright | Buy |
2024-03-04 | 개시 | H.C. Wainwright | Buy |
2021-04-13 | 개시 | Jefferies | Buy |
2021-04-13 | 개시 | Piper Sandler | Overweight |
2021-04-13 | 개시 | SVB Leerink | Outperform |
코넥트 바이오파마 주식(CNTB)의 최신 뉴스
Connect Biopharma reports positive data for asthma treatment By Investing.com - Investing.com South Africa
Connect Biopharma Presents Data Supporting Rademikibart at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual Congress - GlobeNewswire Inc.
Connect Biopharma begins Phase 2 asthma study - Investing.com
Connect Biopharma stock hits 52-week low at $0.55 amid market challenges By Investing.com - Investing.com South Africa
Connect Biopharma stock hits 52-week low at $0.55 amid market challenges - Investing.com
FDA greenlights Connect Biopharma’s asthma and COPD trials - Investing.com
Connect Biopharma stock holds $8 target, Buy rating at H.C. Wainwright - Investing.com
Connect Biopharma faces Nasdaq delisting over share price By Investing.com - Investing.com India
Connect Biopharma faces Nasdaq delisting over share price - Investing.com
Connect Biopharma stock hits 52-week low at $0.76 - Investing.com
Connect Biopharma stock hits 52-week low at $0.91 amid market challenges - Investing.com India
Form N-CSR FIDELITY CONCORD STREET For: Nov 30 - StreetInsider.com
Top 3 Aerospace and Defense Stocks Flying Under the Radar - The Globe and Mail
CPIX Stock Quote Price and Forecast - CNN
Stocks Set to Open Lower as Investors Await Fed Meeting, Banking Sector Remains in Focus - Barchart.com
What should you do if you own US-listed Chinese stocks ordered by SEC to delist? - Dr Wealth
HFCAA News: 128 Chinese Stocks the SEC Could Delist - InvestorPlace
Making it harder to "buy" China, Inc. - USC-China Institute
ICE Announces Annual Reconstitution Changes in the ICE Biotechnology Index - Business Wire
Connect Biopharma Holdings Limited: Shareholders Board Members Managers and Company Profile | US2075231017 - Marketscreener.com
Connect Biopharma (CNTB) Stock Price, News & Analysis - MarketBeat
코넥트 바이오파마 (CNTB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):